Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDICT: Phenotyping Pain Pharmacotherapy in Knee Osteoarthritis
NCT06245109Phase 4Recruiting
- Sponsor
- Northwestern University
- Start
- Feb 2024
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of duloxetine, celecoxib oral solution in knee osteoarthritis (OA), sponsored by Northwestern University. Started Feb 2024; status: recruiting.
02
Drugs
duloxetinecelecoxib oral solution
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06245109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06245109.